中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
6期
165-167,170
,共4页
文拉法辛%认知行为干预%帕金森症%抑郁
文拉法辛%認知行為榦預%帕金森癥%抑鬱
문랍법신%인지행위간예%파금삼증%억욱
Venlafaxine%Cognitive behavioral intervention%Parkinson's disease%Depression
目的:探讨文拉法辛联合认知行为疗法治疗帕金森症合并抑郁、认知功能障碍的临床疗效。方法选择58例帕金森症合并抑郁患者,根据治疗方法分为联合组和对照组。对照组给予文拉法辛胶囊口服治疗,联合组在此基础上给予认知行为疗法,比较两组患者的临床疗效。结果两组组内比较,治疗后焦虑、抑郁评分显著下降(P<0.01),治疗后两组组间比较,联合组评分显著低于对照组(P<0.01)。联合组在干预后认知功能总分、视空间与执行能力、命名能力、语言能力、延迟回忆以及定向力评分显著高于对照组(P<0.01)。结论文拉法辛联合认知行为干预治疗帕金森症合并抑郁、认知功能障碍,具有较好的临床疗效,能够显著改善患者焦虑、抑郁、认知功能障碍等情况。
目的:探討文拉法辛聯閤認知行為療法治療帕金森癥閤併抑鬱、認知功能障礙的臨床療效。方法選擇58例帕金森癥閤併抑鬱患者,根據治療方法分為聯閤組和對照組。對照組給予文拉法辛膠囊口服治療,聯閤組在此基礎上給予認知行為療法,比較兩組患者的臨床療效。結果兩組組內比較,治療後焦慮、抑鬱評分顯著下降(P<0.01),治療後兩組組間比較,聯閤組評分顯著低于對照組(P<0.01)。聯閤組在榦預後認知功能總分、視空間與執行能力、命名能力、語言能力、延遲迴憶以及定嚮力評分顯著高于對照組(P<0.01)。結論文拉法辛聯閤認知行為榦預治療帕金森癥閤併抑鬱、認知功能障礙,具有較好的臨床療效,能夠顯著改善患者焦慮、抑鬱、認知功能障礙等情況。
목적:탐토문랍법신연합인지행위요법치료파금삼증합병억욱、인지공능장애적림상료효。방법선택58례파금삼증합병억욱환자,근거치료방법분위연합조화대조조。대조조급여문랍법신효낭구복치료,연합조재차기출상급여인지행위요법,비교량조환자적림상료효。결과량조조내비교,치료후초필、억욱평분현저하강(P<0.01),치료후량조조간비교,연합조평분현저저우대조조(P<0.01)。연합조재간예후인지공능총분、시공간여집행능력、명명능력、어언능력、연지회억이급정향력평분현저고우대조조(P<0.01)。결논문랍법신연합인지행위간예치료파금삼증합병억욱、인지공능장애,구유교호적림상료효,능구현저개선환자초필、억욱、인지공능장애등정황。
Objective To discuss clinical efficacy of venlafaxine combined with cognitive behavioral intervention for Parkinson's disease with depression and cognitive dysfunction. Methods 58 cases of Parkinson's disease with depression and cognitive dysfunction were selected, and they were divided into combination group and control group according to treatment methods. Control group was treated by venlafaxine treatment. Combination group was treated by venlafaxine combined with cognitive behavioral intervention treatment. Clinical efficacy of two groups were compared. Results After treatment, HAMA and HAMD scores of two groups decreased apparently(P<0.01). HAMA and HAMD scores of combination group after treatment were lower than those of control group(P < 0.01). Cognitive function scores, depending on space and ability to execute, naming ability, language ability, delayed recall and disorientation ratings of combination group after treatment were higher than those of control group(P<0.01). Conclusion Venlafaxine combined with cognitive behavioral intervention for Parkinson's disease with depression and cognitive dysfunction shows better clinical efficacy, relieves depression and anxiety, and improves cognitive function.